5MZ7 image
Deposition Date 2017-01-31
Release Date 2017-10-04
Last Version Date 2024-01-17
Entry Detail
PDB ID:
5MZ7
Title:
Crystal Structure of the third PDZ domain from the synaptic protein PSD-95 with incorporated Azidohomoalanine
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.53 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Disks large homolog 4
Gene (Uniprot):Dlg4
Chain IDs:A, B, C, D
Chain Length:101
Number of Molecules:4
Biological Source:Rattus norvegicus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
AZH A ILE modified residue
Primary Citation
Impact of Azidohomoalanine Incorporation on Protein Structure and Ligand Binding.
Chembiochem 18 2340 2350 (2017)
PMID: 28950050 DOI: 10.1002/cbic.201700437

Abstact

The impact of the incorporation of a non-natural amino acid (NNAA) on protein structure, dynamics, and ligand binding has not been studied rigorously so far. NNAAs are regularly used to modify proteins post-translationally in vivo and in vitro through click chemistry. Herein, structural characterisation of the impact of the incorporation of azidohomoalanine (AZH) into the model protein domain PDZ3 is examined by means of NMR spectroscopy and X-ray crystallography. The structure and dynamics of the apo state of AZH-modified PDZ3 remain mostly unperturbed. Furthermore, the binding of two PDZ3 binding peptides are unchanged upon incorporation of AZH. The interface of the AZH-modified PDZ3 and an azulene-linked peptide for vibrational energy transfer studies has been mapped by means of chemical shift perturbations and NOEs between the unlabelled azulene-linked peptide and the isotopically labelled protein. Co-crystallisation and soaking failed for the peptide-bound holo complex. NMR spectroscopy, however, allowed determination of the protein-ligand interface. Although the incorporation of AZH was minimally invasive for PDZ3, structural analysis of NNAA-modified proteins through the methodology presented herein should be performed to ensure structural integrity of the studied target.

Legend

Protein

Chemical

Disease

Primary Citation of related structures